University of Cape Coast Institutional Repository

Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients

Show simple item record

dc.contributor.author Antwi-Boasiako, Charles
dc.contributor.author Frimpong, Emmanuel
dc.contributor.author Gyan, Ben
dc.contributor.author Kyei-Baafour, Eric
dc.contributor.author Sey, Fredericka
dc.contributor.author Dzudzor, Bartholomew
dc.contributor.author Abdul-Rahman, Mubarak
dc.contributor.author Dankwah, Gifty B.
dc.contributor.author Otu, Kate H.
dc.contributor.author Ndanu, Tom A.
dc.contributor.author Campbell, Andrew D.
dc.contributor.author Ekem, Ivy
dc.contributor.author Donkor, Eric S.
dc.date.accessioned 2023-10-11T19:15:18Z
dc.date.available 2023-10-11T19:15:18Z
dc.date.issued 2018
dc.identifier.uri http://hdl.handle.net/123456789/9304
dc.description.abstract Sickle cell disease (SCD) is an inherited blood disorder that can result in vasculopathy and end organ damage. Angiogenesis has been implicated as a key contributing factor to vascular mediated tissue injury in SCD. The relative plasma levels of angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and vascular endothelial growth factor (VEGF) greatly influence angiogenesis. Dysregulation of these growth factors, leading to a pro-angiogenic state in SCD patients, has been documented in the developed world but there is very little data in Africa. There is the need, therefore, for studies in Ghanaian SCD patients. The aim of this study was to assess plasma levels of Ang-1, Ang-2, and VEGF in homozygous (HbSS) SCD patients with or without complications and healthy controls (HbAA) in Ghana. The study was a case-control study involving 544 participants: 396 HbSS SCD patients and 148 HbAA healthy controls. The study was conducted at the Center for Clinical Genetics (Sickle Cell Clinic) and Accra Area Blood Centre for National Blood transfusion at the Korle-Bu Teaching Hospital, Accra, Ghana. The plasma levels of Ang-1, Ang-2, and VEGF of study participants were measured with a double sandwich enzyme-linked immunosorbent assay (ELISA) technique. Complete blood count (CBC) was measured with an autoanalyser. The mean plasma Ang-1, Ang-2, and VEGF were significantly higher in HbSS SCD patients with or without complications than healthy controls (p < 0.001). The Ang-2/Ang-1 ratio was significantly lower in the controls than the HbSS patients (p < 0.001). The Ang-2/Ang-1 ratio was higher in the HbSS patients with leg ulcers as compared with patients with other complications and healthy controls (p < 0.001). There were higher leucocyte counts in HbSS patients than healthy controls. Overall, there was elevated plasma levels of Ang-1, Ang-2, and VEGF in SCD patients. The higher Ang-2/Ang-1 plasma levels in patients with leg ulcers suggests a possible ongoing angiogenesis and response to inflammatory stimuli. The study provides a first report on plasma levels of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factors in homozygous sickle cell disease patients in Ghana. en_US
dc.language.iso en en_US
dc.publisher Medical Sciences en_US
dc.subject sickle cell disease en_US
dc.subject angiogenic factors en_US
dc.subject angiopoietin-1 en_US
dc.subject angiopoietin-2 en_US
dc.subject vascular endothelial growth factor en_US
dc.title Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search UCC IR


Advanced Search

Browse

My Account